- Home
- OSUR vs MGTX Comparison
OSUR vs MGTX Comparison
Compare OSUR & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- MGTX
- Stock Information
- Founded
- OSUR 2000
- MGTX 2015
- Country
- OSUR United States
- MGTX United States
- Employees
- OSUR N/A
- MGTX N/A
- Industry
- OSUR Medical/Dental Instruments
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OSUR Health Care
- MGTX Health Care
- Exchange
- OSUR Nasdaq
- MGTX Nasdaq
- Market Cap
- OSUR 334.1M
- MGTX 411.4M
- IPO Year
- OSUR 1986
- MGTX N/A
- Fundamental
- Price
- OSUR $4.13
- MGTX $5.98
- Analyst Decision
- OSUR Buy
- MGTX Strong Buy
- Analyst Count
- OSUR 3
- MGTX 2
- Target Price
- OSUR $6.67
- MGTX $22.50
- AVG Volume (30 Days)
- OSUR 459.6K
- MGTX 325.1K
- Earning Date
- OSUR 11-05-2024
- MGTX 11-12-2024
- Dividend Yield
- OSUR N/A
- MGTX N/A
- EPS Growth
- OSUR N/A
- MGTX N/A
- EPS
- OSUR 0.36
- MGTX N/A
- Revenue
- OSUR $273,535,000.00
- MGTX $8,122,000.00
- Revenue This Year
- OSUR N/A
- MGTX $133.83
- Revenue Next Year
- OSUR N/A
- MGTX $655.34
- P/E Ratio
- OSUR $11.35
- MGTX N/A
- Revenue Growth
- OSUR N/A
- MGTX 26.87
- 52 Week Low
- OSUR $3.92
- MGTX $3.49
- 52 Week High
- OSUR $8.45
- MGTX $7.60
- Technical
- Relative Strength Index (RSI)
- OSUR 45.49
- MGTX 78.17
- Support Level
- OSUR $4.00
- MGTX $3.97
- Resistance Level
- OSUR $4.16
- MGTX $6.24
- Average True Range (ATR)
- OSUR 0.08
- MGTX 0.33
- MACD
- OSUR 0.01
- MGTX 0.20
- Stochastic Oscillator
- OSUR 57.89
- MGTX 88.56
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.